[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350979-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-350979-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","ufmylation-deficiency-in-hepatocytes-activates-the-keap1-nrf2-pathway-and-contributes-to-hepatocarcinogenesis","UFMylation deficiency in hepatocytes activates the KEAP1-NRF2 pathway and contributes to hepatocarcinogenesis","","The Kelch-like ECH-associated protein 1 (KEAP1)-NRF2 pathway is central to maintaining cellular redox balance, and aberrant activation contributes to malignancies including hepatocellular carcinoma, yet its mechanisms are unclear. UFMylation, a ubiquitin-like modification, has important biological roles and its deficiency is linked to disease. Here, hepatocyte-specific Ufl1 knockout in mice causes hepatic pathology and promotes diethylnitrosamine-induced hepatocarcinogenesis.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/ufmylation-deficiency-in-hepatocytes-activates-the-keap1-nrf2-pathway-and-contributes-to-hepatocarcinogenesis/350979/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/ufmylation-deficiency-in-hepatocytes-activates-the-keap1-nrf2-pathway-and-contributes-to-hepatocarcinogenesis/350979.png","ImageObject",300,407,{"name":42,"@type":43},"Hazel","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main redox pathway discussed in the study?","Question",{"text":63,"@type":64},"The study focuses on the KEAP1-NRF2 pathway, which maintains cellular redox balance and supports cytoprotective responses to oxidative stress.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does UFL1/UFMylation deficiency affect hepatocarcinogenesis in mice?",{"text":68,"@type":64},"Hepatocyte-specific Ufl1 knockout leads to hepatic pathological alterations and promotes diethylnitrosamine-induced hepatocarcinogenesis.",{"name":70,"@type":61,"acceptedAnswer":71},"What mechanistic link is identified between UFMylation and KEAP1-NRF2 signaling?",{"text":72,"@type":64},"KEAP1 is identified as an UFMylation substrate; loss of UFMylation modification triggers ubiquitin-mediated degradation of KEAP1, causing NRF2 nuclear accumulation and activation of the pathway.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},350979,1790566178,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","Redox Biology 90 (2026) 104046  \nContents lists available at ScienceDirect  \nRedox Biology  \njournal [homepage:](homepage: www.elsevier.com/locate/redox)[ www.elsevier.com/locate/redox](homepage: www.elsevier.com/locate/redox)  \n| UFMylation deficiency in hepatocytes activates the KEAP1-NRF2 pathway and contributes to hepatocarcinogenesis\u003Cbr>Qian Lianga,1, Shiwen Xu a,1, Yaoyao Fanga, Xue Wang a, Yang Xiao a, Yiwen Wang a, Shujuan Lia, Qifan Guo a, Yu Caoa, Ying Cao a, Chao Liu a, Yuqin Zhao a, Yan Luob, Anqi Wu c, Miao Wang a, Junping Shi b, Guoqing Li c,*, Yu-Sheng Conga,**\u003Cbr>a Zhejiang Key Laboratory of Medical Epigenetics, School of Basic Medical Sciences, Key Laboratory of Aging and Cancer Biology of Zhejiang Province, Hangzhou Normal University, Hangzhou, 311121, China\u003Cbr>b Department of Infectious and Hepatology Diseases, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, 310015, China\u003Cbr>c Hunan Provincial Key Laboratory of Basic and Clinical Pharmacological Research of Gastrointestinal Cancer, the Second Affiliated Hospital, University of South China, Hengyang, 421001, China |  |  |\n| --- | --- | --- |\n| A R T I C L E I N F O |  | A B S T R A C T |\n| Keywords: UFMylation UFL1\u003Cbr>KEAP1-NRF2 pathway Hepatocytes Hepatocellular carcinoma |  | The Kelch-like ECH-associated protein 1 (KEAP1) -Nuclear factor erythroid 2-related factor 2 (NRF2) pathway plays a central role in maintaining cellular redox balance, aberrant activation of the KEAP1-NRF2 pathway is involved in a variety of human malignant tumors including hepatocellular carcinoma. However, the underlying mechanisms remain unclear. UFMylation is a type of ubiquitin-like modifications with important biological functions, its deficiency is implicated in several pathogenesis. In this study, we show that hepatocyte specific Ufl1 knockout in mice results in several hepatic pathological alterations and promotes the development of diethylnitrosamine (DEN)-induced hepatocarcinogenesis. Furthermore, we identified KEAP1 as an UFMylation substrate, and deficiency in UFMylation modification resulted in ubiquitin-mediated degradation of KEAP1, and subsequent nuclear accumulation of NRF2, and activation of the KEAP1-NRF2 pathway. Consistently, we found that UFL1 expression is decreased and positively correlated with the level of KEAP1 in liver cancer samples. Our results suggest that UFL1 plays an important role in liver pathophysiology, in part by regulating the KEAP1-NRF2 pathway, thus provides novel insights into the molecular basis of hepatocarcinogenesis. |\n\n1. Introduction  \nLiver cancer is one of the leading causes of cancer deaths worldwide. Hepatocellular carcinoma (HCC) is the most prevalent type of primary liver cancer which constitutes more than 90 % of cases [1]. HCC frequently arises in individuals with chronic liver disease stemming from diverse risk factors, such as hepatoviral infections, exposure to hepatic carcinogens, and unhealthy lifestyles [2]. Current opinion holds that the development of HCC is a stepwise progression from chronic liver injury and inflammation to fibrosis and/or cirrhosis and eventually to liver cancer [3]. Because of its critical metabolic and detoxification functions, liver is an important site of reactive oxygen species (ROS) production. Over time, an imbalance between the production and accumulation of ROS causes oxidative stress, leading to damage to  \nlipids, proteins and DNA, which progressively cause chronic liver injury, inflammation and eventually oncogenic transformation [4].  \nThe Kelch-like ECH-associated protein 1 (KEAP1) - Nuclear factor erythroid 2-related factor 2 (NRF2) pathway plays a pivotal role in cytoprotective responses to endogenous and exogenous stresses caused by ROS [5]. As a transcription factor, NRF2 binds to the antioxidant response elements (AREs) and activates transcription of a large number of downstream genes involved in multiple cellular pathways essential for homeostasis maintenance [6]. ","cbCaiqFKDU8T81ia","https://ap.wps.com/l/cbCaiqFKDU8T81ia","pdf",12532334,"English","# Introduction\n## Liver cancer background and ROS-driven progression\n## KEAP1-NRF2 pathway role in cytoprotection\n## Regulation of NRF2 by KEAP1 and cancer relevance\n## Post-translational modifications of KEAP1\n## UFM1/UFMylation and rationale for study","[{\"question\":\"What is the main redox pathway discussed in the study?\",\"answer\":\"The study focuses on the KEAP1-NRF2 pathway, which maintains cellular redox balance and supports cytoprotective responses to oxidative stress.\"},{\"question\":\"How does UFL1/UFMylation deficiency affect hepatocarcinogenesis in mice?\",\"answer\":\"Hepatocyte-specific Ufl1 knockout leads to hepatic pathological alterations and promotes diethylnitrosamine-induced hepatocarcinogenesis.\"},{\"question\":\"What mechanistic link is identified between UFMylation and KEAP1-NRF2 signaling?\",\"answer\":\"KEAP1 is identified as an UFMylation substrate; loss of UFMylation modification triggers ubiquitin-mediated degradation of KEAP1, causing NRF2 nuclear accumulation and activation of the pathway.\"}]","UFMylation deficiency in hepatocytes activates the KEAP1-NRF2 pathway and contributes to hepatocarcinogenesis | PDF",1790092187,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aa25cb852d735dffd70761a082c1580d.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e3ae242febe52597c99073ed52760c16.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/44713969ae7cf17e5e0a6e199f12cc0b.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a339be1ae891dee4d2e7e8eec9cc7395.webp",980,1306]